Recent studies on CRC showed that glucagon (GCG) might promote tumor progression by stimulating tumor angiogenesis or tumor cell proliferation.[23, 24] However, the underlying mechanisms are poorly understood and little is known about their role in tumor development. The gene discussed is GCG; the disease is colorectal carcinoma.